Paper28366377
Treatment of cystoid macular edema after cataract surgery.
Wielders LH and 7 others. J Cataract Refract Surg, 2017. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Treatment of cystoid macular edema after cataract surgery. Papers, record 28366377. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28366377
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents, Non-Steroidal | Major topic |
| Cataract Extraction | Major topic |
| Macular Edema | Major topic |
| Diabetes Mellitus | |
| Humans | |
| Postoperative Complications | |
| Risk Factors | |
| Visual Acuity |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42590202 | Association of Systemic and Ocular Comorbidities with Visual Recovery in Patients with Postoperative Corneal Oedema: A Real-World Study of Cataract Surgery Outcomes. | J Clin Med | 2026 | https://conductscience.org/library/papers/42590202 | PubMed |
| 42292706 | Bromfenac with Sodium Bisulfite Inducing Contact Dermatitis and Corneal Ring Infiltrate: A Case Report. | Case Rep Ophthalmol | 2026 | https://conductscience.org/library/papers/42292706 | PubMed |
| 41003131 | Irvine-Gass Syndrome Personalized Treatment Outcomes: A Retrospective Single-Center Cohort Study. | J Pers Med | 2025 | https://conductscience.org/library/papers/41003131 | PubMed |
| 40909035 | Cystoid Macular Edema Following Phacoemulsification and Posterior Chamber Intraocular Lens Surgery: An Aspect From the Past to the Present. | Cureus | 2025 | https://conductscience.org/library/papers/40909035 | PubMed |
| 37723463 | Real-world treatment patterns and economic burden of post-cataract macular edema. | BMC Ophthalmol | 2023 | https://conductscience.org/library/papers/37723463 | PubMed |
| 36607976 | Safety of the bag-in-the-lens implantation regarding the development of clinically significant pseudophakic cystoid macular edema: A retrospective case series study. | PLoS One | 2023 | https://conductscience.org/library/papers/36607976 | PubMed |
| 34967932 | Cataract Surgery Considerations for Diabetic Patients. | Curr Diab Rep | 2021 | https://conductscience.org/library/papers/34967932 | PubMed |
| 34759667 | Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis. | Middle East Afr J Ophthalmol | 2021 | https://conductscience.org/library/papers/34759667 | PubMed |
| 33384889 | Safety and Comfort of an Innovative Drug Delivery Device in Healthy Subjects. | Transl Vis Sci Technol | 2020 | https://conductscience.org/library/papers/33384889 | PubMed |
| 33192068 | Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema. | Ther Clin Risk Manag | 2020 | https://conductscience.org/library/papers/33192068 | PubMed |
| 33078109 | Comparison of intravitreal anti-vascular endothelial growth factor agents and treatment results in Irvine-Gass syndrome. | Int J Ophthalmol | 2020 | https://conductscience.org/library/papers/33078109 | PubMed |
| 32440977 | Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis. | Adv Ther | 2020 | https://conductscience.org/library/papers/32440977 | PubMed |
| 30614750 | Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study. | J Ocul Pharmacol Ther | 2019 | https://conductscience.org/library/papers/30614750 | PubMed |
| 29785993 | Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac. | Indian J Ophthalmol | 2018 | https://conductscience.org/library/papers/29785993 | PubMed |
| 29560479 | Topical interferon alpha 2b in the treatment of refractory pseudophakic cystoid macular edema. | Am J Ophthalmol Case Rep | 2018 | https://conductscience.org/library/papers/29560479 | PubMed |
| 29459782 | Distinct macular thickness changes after femtosecond laser-assisted cataract surgery of age-related cataract and myopia with cataract. | Sci Rep | 2018 | https://conductscience.org/library/papers/29459782 | PubMed |
| 29269999 | Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives. | Clin Ophthalmol | 2017 | https://conductscience.org/library/papers/29269999 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28366377
GET https://conductscience.org/api/papers/v1/28366377/authors